Vis enkel innførsel

dc.contributor.authorNichols, Emma
dc.contributor.authorSteinmetz, Jaimie D
dc.contributor.authorVollset, Stein Emil
dc.contributor.authorFukutaki, Kai
dc.contributor.authorChalek, Julian
dc.contributor.authorKisa, Adnan
dc.contributor.authorMurray, Christopher J L
dc.contributor.authorMokdad, Ali H.
dc.contributor.authorHay, Simon I.
dc.contributor.authorKisa, Sezer
dc.contributor.authorVos, Theo
dc.contributor.authorZastrozhin, Mikhail Sergeevich
dc.contributor.authorForecasting Collaborators, GBD 2019 Dementia
dc.date.accessioned2022-02-21T09:39:54Z
dc.date.available2022-02-21T09:39:54Z
dc.date.created2022-01-07T12:56:03Z
dc.date.issued2022-02-02
dc.identifier.citationThe Lancet Public Health. 2022, .en_US
dc.identifier.issn2468-2667
dc.identifier.urihttps://hdl.handle.net/11250/2980408
dc.description.abstractBackground: Given the projected trends in population ageing and population growth, the number of people with dementia is expected to increase. In addition, strong evidence has emerged supporting the importance of potentially modifiable risk factors for dementia. Characterising the distribution and magnitude of anticipated growth is crucial for public health planning and resource prioritisation. This study aimed to improve on previous forecasts of dementia prevalence by producing country-level estimates and incorporating information on selected risk factors. Methods: We forecasted the prevalence of dementia attributable to the three dementia risk factors included in the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 (high body-mass index, high fasting plasma glucose, and smoking) from 2019 to 2050, using relative risks and forecasted risk factor prevalence to predict GBD risk-attributable prevalence in 2050 globally and by world region and country. Using linear regression models with education included as an additional predictor, we then forecasted the prevalence of dementia not attributable to GBD risks. To assess the relative contribution of future trends in GBD risk factors, education, population growth, and population ageing, we did a decomposition analysis. Findings: We estimated that the number of people with dementia would increase from 57·4 (95% uncertainty interval 50·4–65·1) million cases globally in 2019 to 152·8 (130·8–175·9) million cases in 2050. Despite large increases in the projected number of people living with dementia, age-standardised both-sex prevalence remained stable between 2019 and 2050 (global percentage change of 0·1% [–7·5 to 10·8]). We estimated that there were more women with dementia than men with dementia globally in 2019 (female-to-male ratio of 1·69 [1·64–1·73]), and we expect this pattern to continue to 2050 (female-to-male ratio of 1·67 [1·52–1·85]). There was geographical heterogeneity in the projected increases across countries and regions, with the smallest percentage changes in the number of projected dementia cases in high-income Asia Pacific (53% [41–67]) and western Europe (74% [58–90]), and the largest in north Africa and the Middle East (367% [329–403]) and eastern sub-Saharan Africa (357% [323–395]). Projected increases in cases could largely be attributed to population growth and population ageing, although their relative importance varied by world region, with population growth contributing most to the increases in sub-Saharan Africa and population ageing contributing most to the increases in east Asia. Interpretation: Growth in the number of individuals living with dementia underscores the need for public health planning efforts and policy to address the needs of this group. Country-level estimates can be used to inform national planning efforts and decisions. Multifaceted approaches, including scaling up interventions to address modifiable risk factors and investing in research on biological mechanisms, will be key in addressing the expected increases in the number of individuals affected by dementia.en_US
dc.description.sponsorshipFunding provided by Bill & Melinda Gates Foundation and Gates Ventures.en_US
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.relation.ispartofseriesThe Lancet Public Health;Volume 7, Issue 2, February 2022, Pages e105-e125
dc.relation.urihttps://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(21)00249-8/fulltext#supplementaryMaterial
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.subjectDementiaen_US
dc.subjectPrevalence forecastsen_US
dc.subjectPopulation ageingen_US
dc.subjectPublic healthen_US
dc.subjectDementia forecastsen_US
dc.titleEstimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019en_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2022 The Author(s).en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doihttps://doi.org/10.1016/S2468-2667(21)00249-8
dc.identifier.cristin1976549
dc.source.journalThe Lancet Public Healthen_US
dc.source.volume7en_US
dc.source.issue2en_US
dc.source.pagenumber21en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal